Early cranial stereotactic radiotherapy (SRT) administered with first-line osimertinib was associated with improved ...

A newly proposed International Association for the Study of Lung Cancer (IASLC) tumor budding-based grading system ...

Adding zipalertinib to platinum-pemetrexed chemotherapy significantly improved progression-free survival in patients ...

New diagnoses of cannabis use disorder (CUD) among adolescents in Northern California began climbing after recreational ...

New results from the global Phase I/II ARROS-1 trial showed clinically meaningful activity with zidesamtinib in patients with advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC) ...

In the SWOG S1827 MAVERICK phase III randomized trial, patients with small-cell lung cancer (SCLC) who underwent regular brain MRI surveillance without prophylactic cranial irradiation (PCI) had ...

An exploratory eight-year landmark update from the Phase III ADAURA trial showed that adjuvant osimertinib continued to ...

Results from the international phase III SWOG S1827 MAVERICK trial show that brain MRI surveillance alone improved cognitive failure-free survival compared with MRI surveillance plus prophylactic ...

The phase III TAISHAN-302 trial found that tambotatug pelitecan (Tam-Peli, YL201), a novel anti-B7-H3 antibody-drug conjugate, significantly improved overall survival, progression-free survival and ...

First-line treatment with trastuzumab deruxtecan (T-DXd) significantly improved progression-free survival compared with ...

Researchers have found a high level of agreement between cataract referral decisions based on smartphone images reviewed ...

People who live in areas with higher levels of air pollution are more likely to develop glaucoma and cataract, according to a ...